/
News,
Research
Genome editing to protect therapeutic hematopoietic cells from targeted immunotherapy (Jeker Lab)
When targeting acute myeloid leukemia (AML) with monoclonal antibodies, antibody drug conjugates, T cell engagers or chimeric antigen receptor (CAR) cells, a major challenge lies in avoiding myelotoxicity. This issue arises because many of…